Octreotide Acetate: 5 recalls on record

Recalled by 1 agency: FDA (5).

First recall on record: November 16, 2022. Most recent: May 13, 2026.

Risk classification: Class I: 1 · Class II: 4

Most recent recalls

DateAgencyProduct
May 13, 2026FDAOctreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Si…D-0519-2026
April 1, 2026FDAOctreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, Singl…D-0406-2026
April 1, 2026FDAOctreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 20 mg, Singl…D-0405-2026
April 1, 2026FDAOctreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 10 mg, Singl…D-0404-2026
November 16, 2022FDAOctreotide Acetate Injection 500 mcg/mL, 10 x 1 mL Single-Dose Unit-of-Use Syringes, For …D-0058-2023

Questions about this brand

How many recalls does Octreotide Acetate have?
Recalert has 5 U.S. recalls on record for Octreotide Acetate, published between November 16, 2022 and May 13, 2026.
What was the most recent Octreotide Acetate recall?
FDA recall D-0519-2026, published May 13, 2026: Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, 30 mg, In Single-Dose kits containing: 8-mL vial of 30 mg strength, a pre-filled syringe containing 2 mL of diluent, one v…
Which agencies have recalled Octreotide Acetate products?
Octreotide Acetate products appear in recalls from: FDA (5).

Do you sell Octreotide Acetate products? Check your whole catalog free against 80,000+ recalls.

Paste up to 100 UPCs or SKUs and see which ones match a CPSC, FDA, NHTSA or FSIS recall. No account needed.

Check my catalog free

Want it checked every night instead? Starter watches 500 SKUs for $29/month. See plans

Related brands